338 related articles for article (PubMed ID: 31589177)
21. D-livering the message: the importance of vitamin D status in chronic liver disease.
Kitson MT; Roberts SK
J Hepatol; 2012 Oct; 57(4):897-909. PubMed ID: 22634121
[TBL] [Abstract][Full Text] [Related]
22. Hepatocyte vitamin D receptor regulates lipid metabolism and mediates experimental diet-induced steatosis.
Bozic M; Guzmán C; Benet M; Sánchez-Campos S; García-Monzón C; Gari E; Gatius S; Valdivielso JM; Jover R
J Hepatol; 2016 Oct; 65(4):748-757. PubMed ID: 27245430
[TBL] [Abstract][Full Text] [Related]
23. Vitamin D deficiency in non-alcoholic fatty liver disease: The chicken or the egg?
Lee SM; Jun DW; Cho YK; Jang KS
Clin Nutr; 2017 Feb; 36(1):191-197. PubMed ID: 26615912
[TBL] [Abstract][Full Text] [Related]
24. Active vitamin D supplementation alleviates initiation and progression of nonalcoholic fatty liver disease by repressing the p53 pathway.
Liu Y; Wang M; Xu W; Zhang H; Qian W; Li X; Cheng X
Life Sci; 2020 Jan; 241():117086. PubMed ID: 31756344
[TBL] [Abstract][Full Text] [Related]
25. Vitamin D supplementation for the treatment of non-alcoholic fatty liver disease: A randomized double blind placebo controlled trial.
Dabbaghmanesh MH; Danafar F; Eshraghian A; Omrani GR
Diabetes Metab Syndr; 2018 Jul; 12(4):513-517. PubMed ID: 29588137
[TBL] [Abstract][Full Text] [Related]
26. Is Vitamin D an Independent Risk Factor of Nonalcoholic Fatty Liver Disease?: a Cross-Sectional Study of the Healthy Population.
Park D; Kwon H; Oh SW; Joh HK; Hwang SS; Park JH; Yun JM; Lee H; Chung GE; Ze S; Park JH; Bae Y; Lee A
J Korean Med Sci; 2017 Jan; 32(1):95-101. PubMed ID: 27914137
[TBL] [Abstract][Full Text] [Related]
27. Vitamin D: a new player in non-alcoholic fatty liver disease?
Eliades M; Spyrou E
World J Gastroenterol; 2015 Feb; 21(6):1718-27. PubMed ID: 25684936
[TBL] [Abstract][Full Text] [Related]
28. Meta-analysis: vitamin D and non-alcoholic fatty liver disease.
Eliades M; Spyrou E; Agrawal N; Lazo M; Brancati FL; Potter JJ; Koteish AA; Clark JM; Guallar E; Hernaez R
Aliment Pharmacol Ther; 2013 Aug; 38(3):246-54. PubMed ID: 23786213
[TBL] [Abstract][Full Text] [Related]
29. Association between Vitamin D Status and Non-Alcoholic Fatty Liver Disease: A Population-Based Study.
Liu S; Liu Y; Wan B; Zhang H; Wu S; Zhu Z; Lin Y; Wang M; Zhang N; Lin S; Zhu Y
J Nutr Sci Vitaminol (Tokyo); 2019; 65(4):303-308. PubMed ID: 31474679
[TBL] [Abstract][Full Text] [Related]
30. Association of nonalcoholic fatty liver disease with serum vitamin D levels in combination of physical fitness in korean older adults.
Lee I; Park E; Cho J
J Steroid Biochem Mol Biol; 2020 Apr; 198():105569. PubMed ID: 31891747
[TBL] [Abstract][Full Text] [Related]
31. The Association between Vitamin D Insufficiency and Nonalcoholic Fatty Liver Disease: A Population-Based Study.
Ha Y; Hwang SG; Rim KS
Nutrients; 2017 Jul; 9(8):. PubMed ID: 28749418
[TBL] [Abstract][Full Text] [Related]
32. Vitamin D deficiency: prevalence and association with liver disease severity in pediatric nonalcoholic fatty liver disease.
Yodoshi T; Orkin S; Arce-Clachar AC; Bramlage K; Liu C; Fei L; El-Khider F; Dasarathy S; Xanthakos SA; Mouzaki M
Eur J Clin Nutr; 2020 Mar; 74(3):427-435. PubMed ID: 31444465
[TBL] [Abstract][Full Text] [Related]
33. Effect of daily calcitriol supplementation with and without calcium on disease regression in non-alcoholic fatty liver patients following an energy-restricted diet: Randomized, controlled, double-blind trial.
Lorvand Amiri H; Agah S; Tolouei Azar J; Hosseini S; Shidfar F; Mousavi SN
Clin Nutr; 2017 Dec; 36(6):1490-1497. PubMed ID: 27720403
[TBL] [Abstract][Full Text] [Related]
34. A New Light on Vitamin D in Obesity: A Novel Association with Trimethylamine-N-Oxide (TMAO).
Barrea L; Muscogiuri G; Annunziata G; Laudisio D; de Alteriis G; Tenore GC; Colao A; Savastano S
Nutrients; 2019 Jun; 11(6):. PubMed ID: 31185686
[No Abstract] [Full Text] [Related]
35. Gut microbiota manipulation with prebiotics in patients with non-alcoholic fatty liver disease: a randomized controlled trial protocol.
Lambert JE; Parnell JA; Eksteen B; Raman M; Bomhof MR; Rioux KP; Madsen KL; Reimer RA
BMC Gastroenterol; 2015 Dec; 15():169. PubMed ID: 26635079
[TBL] [Abstract][Full Text] [Related]
36. Vitamin D and nonalcoholic fatty liver disease (NAFLD): is it more than just an association?
Kwok RM; Torres DM; Harrison SA
Hepatology; 2013 Sep; 58(3):1166-74. PubMed ID: 23504808
[TBL] [Abstract][Full Text] [Related]
37. Association of serum vitamin D level and nonalcoholic fatty liver disease: a meta-analysis.
Liu T; Xu L; Chen FH; Zhou YB
Eur J Gastroenterol Hepatol; 2020 Feb; 32(2):140-147. PubMed ID: 31895886
[TBL] [Abstract][Full Text] [Related]
38. Nutraceutical Approach to Non-Alcoholic Fatty Liver Disease (NAFLD): The Available Clinical Evidence.
Cicero AFG; Colletti A; Bellentani S
Nutrients; 2018 Aug; 10(9):. PubMed ID: 30142943
[TBL] [Abstract][Full Text] [Related]
39. Relationship between adipose tissue dysfunction, vitamin D deficiency and the pathogenesis of non-alcoholic fatty liver disease.
Cimini FA; Barchetta I; Carotti S; Bertoccini L; Baroni MG; Vespasiani-Gentilucci U; Cavallo MG; Morini S
World J Gastroenterol; 2017 May; 23(19):3407-3417. PubMed ID: 28596677
[TBL] [Abstract][Full Text] [Related]
40. Regression of Non-Alcoholic Fatty Liver by Vitamin D Supplement: A Double-Blind Randomized Controlled Clinical Trial.
Lorvand Amiri H; Agah S; Mousavi SN; Hosseini AF; Shidfar F
Arch Iran Med; 2016 Sep; 19(9):631-8. PubMed ID: 27631178
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]